DE60332534D1 - Chinuclidinamidderivate - Google Patents

Chinuclidinamidderivate

Info

Publication number: DE60332534D1
Authority: DE; Germany
Prior art keywords: chinuclidinamidderivate
Prior art date: 2002-07-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60332534T

Other languages

English (en)

Inventor

Quinones Maria Prat

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Almirall SA

Original Assignee

Almirall SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-02

Filing date

2003-06-25

Publication date

2010-06-24

2003-06-25 Application filed by Almirall SA filed Critical Almirall SA

2010-06-24 Application granted granted Critical

2010-06-24 Publication of DE60332534D1 publication Critical patent/DE60332534D1/de

2023-06-26 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE60332534T 2002-07-02 2003-06-25 Chinuclidinamidderivate Expired - Fee Related DE60332534D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200201539A ES2204295B1 (es)	2002-07-02	2002-07-02	Nuevos derivados de quinuclidina-amida.
PCT/EP2003/006708 WO2004005285A1 (en)	2002-07-02	2003-06-25	New quinuclidine amide derivatives

Publications (1)

Publication Number	Publication Date
DE60332534D1 true DE60332534D1 (de)	2010-06-24

Family

ID=30011350

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60332534T Expired - Fee Related DE60332534D1 (de)	2002-07-02	2003-06-25	Chinuclidinamidderivate

Country Status (24)

Country	Link
US (2)	US7488735B2 (de)
EP (1)	EP1519933B1 (de)
JP (1)	JP2005533826A (de)
CN (1)	CN100404533C (de)
AR (1)	AR040351A1 (de)
AT (1)	ATE467631T1 (de)
AU (1)	AU2003242757B2 (de)
BR (1)	BR0312216A (de)
CA (1)	CA2492535A1 (de)
DE (1)	DE60332534D1 (de)
EC (1)	ECSP045519A (de)
ES (1)	ES2204295B1 (de)
IL (1)	IL165923A (de)
MX (1)	MXPA04012271A (de)
MY (1)	MY130803A (de)
NO (1)	NO20050164L (de)
NZ (1)	NZ537341A (de)
PE (1)	PE20040644A1 (de)
RU (1)	RU2314306C2 (de)
TW (1)	TW200402420A (de)
UA (1)	UA80832C2 (de)
UY (1)	UY27870A1 (de)
WO (1)	WO2004005285A1 (de)
ZA (1)	ZA200410404B (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
ATE305468T1 (de)	2000-12-22	2005-10-15	Almirall Prodesfarma Ag	Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten
ES2203327B1 (es)	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
AR044519A1 (es)	2003-05-02	2005-09-14	Novartis Ag	Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
ES2239546B1 (es) *	2004-03-15	2006-12-01	Almirall Prodesfarma, S.A.	Nuevos esteres de quinuclidina cuaternizados.
PE20060259A1 (es) *	2004-04-27	2006-03-25	Glaxo Group Ltd	Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico
JP2007537261A (ja) *	2004-05-13	2007-12-20	グラクソ　グループ　リミテッド	ムスカリン性アセチルコリン受容体アンタゴニスト
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
ES2246170B1 (es) *	2004-07-29	2007-04-01	Almirall Prodesfarma, S.A.	Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.
ATE469898T1 (de) *	2004-09-15	2010-06-15	Shuqiang Zhao	Chinuclidinverbindungen mit quaternärer ammoniumgruppe, verfahren zu ihrer herstellung und ihre verwendung als acetylcholinblockierende mittel
GT200500281A (es)	2004-10-22	2006-04-24	Novartis Ag	Compuestos organicos.
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0507577D0 (en)	2005-04-14	2005-05-18	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
MY144906A (en)	2005-10-21	2011-11-30	Novartis Ag	Human antibodies against il13 and therapeutic uses
US9088384B2 (en) *	2005-10-27	2015-07-21	Qualcomm Incorporated	Pilot symbol transmission in wireless communication systems
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
RU2457209C2 (ru)	2006-04-21	2012-07-27	Новартис Аг	Производные пурина, предназначенные для применения в качестве агонистов аденозинового рецептора а2а
ES2298049B1 (es) *	2006-07-21	2009-10-20	Laboratorios Almirall S.A.	Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
MX2009003185A (es)	2006-09-29	2009-04-03	Novartis Ag	Pirazolopirimidinas como inhibidores de lipido cinasa pi3k.
HRP20110201T1 (hr)	2007-01-10	2011-08-31	Irm Llc	Spojevi i sastavi kao inhibitori proteaze kanalizirane aktivacije
KR101495708B1 (ko) *	2007-02-23	2015-02-25	세라밴스 바이오파마 알앤디 아이피, 엘엘씨	무스카린 수용체 안타고니스트로 유용한 4차 암모늄 디페닐메틸 화합물
DE602008005140D1 (de)	2007-05-07	2011-04-07	Novartis Ag	Organische verbindungen
AR069637A1 (es)	2007-12-10	2010-02-10	Novartis Ag	Derivados de pirazinas
CN101910153B (zh)	2008-01-11	2014-01-22	诺华股份有限公司	作为激酶抑制剂的嘧啶类
WO2009098455A1 (en) *	2008-02-06	2009-08-13	Astrazeneca Ab	2- (9h-xanthen-9-yl) -oxazol derivatives as m3 muscarinic receptor antagonists for the treatment of asthma and chronic obstructive lung disease
WO2009098453A1 (en) *	2008-02-06	2009-08-13	Astrazeneca Ab	Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists
EP2100599A1 (de)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
US8268834B2 (en)	2008-03-19	2012-09-18	Novartis Ag	Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
WO2009150137A2 (en)	2008-06-10	2009-12-17	Novartis Ag	Organic compounds
GB0814728D0 (en) *	2008-08-12	2008-09-17	Argenta Discovery Ltd	New combination
GB0814729D0 (en) *	2008-08-12	2008-09-17	Argenta Discovery Ltd	New combination
BRPI0917978A2 (pt) *	2008-08-12	2015-11-17	Astrazeneca Ab	sal de 2-hidróxi-etanossulfonato
PT2391366E (pt)	2009-01-29	2013-02-05	Novartis Ag	Benzimidazoles substituídos para o tratamento de astrocitomas
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
BR112012003262A8 (pt)	2009-08-12	2016-05-17	Novartis Ag	compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação
PE20121148A1 (es)	2009-08-17	2012-09-07	Intellikine Llc	Compuestos heterociclicos y usos de los mismos
BR112012008061A2 (pt)	2009-08-20	2016-03-01	Novartis Ag	compostos de oxima heterocíclica
JP2013508414A (ja)	2009-10-22	2013-03-07	バーテックスファーマシューティカルズインコーポレイテッド	嚢胞性線維症および他の慢性疾患の治療のための組成物
US8247436B2 (en)	2010-03-19	2012-08-21	Novartis Ag	Pyridine and pyrazine derivative for the treatment of CF
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
US8372845B2 (en)	2010-09-17	2013-02-12	Novartis Ag	Pyrazine derivatives as enac blockers
EP2673277A1 (de)	2011-02-10	2013-12-18	Novartis AG	[1, 2, 4] triazolo [4, 3]pyridazinverbindungen als inhibitoren dec-met-tyrosinkinase
JP5808826B2 (ja)	2011-02-23	2015-11-10	インテリカイン，エルエルシー	複素環化合物およびその使用
BR112013021638A2 (pt)	2011-02-25	2016-08-02	Irm Llc	"compostos inibidores de trk, seu uso e composições que os compreendem"
EP2510928A1 (de)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
KR20140019409A (ko) *	2011-04-29	2014-02-14	키에시 파르마슈티시 엣스. 피. 에이.	알칼로이드 에스텔 및 카바메이트 유도체와 그들의 의약조성물
UY34305A (es)	2011-09-01	2013-04-30	Novartis Ag	Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
EP2755976B1 (de)	2011-09-15	2018-07-18	Novartis AG	6-substituierte 3-(chinolin-6-ylthio)-[1,2,4-]triazolo-[4,3-a-]pyradine als tyrosinkinase
ES2882807T3 (es)	2011-09-16	2021-12-02	Novartis Ag	Heterociclil carboxamidas N-sustituidas
WO2013038373A1 (en)	2011-09-16	2013-03-21	Novartis Ag	Pyridine amide derivatives
WO2013038381A1 (en)	2011-09-16	2013-03-21	Novartis Ag	Pyridine/pyrazine amide derivatives
CN103946221B (zh)	2011-09-16	2016-08-03	诺华股份有限公司	用于治疗囊性纤维化的杂环化合物
WO2013038378A1 (en)	2011-09-16	2013-03-21	Novartis Ag	Pyridine amide derivatives
US20130209543A1 (en)	2011-11-23	2013-08-15	Intellikine Llc	Enhanced treatment regimens using mtor inhibitors
US8809340B2 (en)	2012-03-19	2014-08-19	Novartis Ag	Crystalline form
JP2015512425A (ja)	2012-04-03	2015-04-27	ノバルティスアーゲー	チロシンキナーゼ阻害剤との組合せ製品及びそれらの使用
US9073921B2 (en)	2013-03-01	2015-07-07	Novartis Ag	Salt forms of bicyclic heterocyclic derivatives
WO2014151147A1 (en)	2013-03-15	2014-09-25	Intellikine, Llc	Combination of kinase inhibitors and uses thereof
EP3023424B1 (de) *	2013-07-13	2019-02-27	Beijing Shuobai Pharmaceutical Co., Ltd.	Chininverbindungen und optische isomere, herstellungsverfahren und medizinische verwendung davon
WO2015084804A1 (en)	2013-12-03	2015-06-11	Novartis Ag	Combination of mdm2 inhibitor and braf inhibitor and their use
EP3134396B1 (de)	2014-04-24	2019-09-18	Novartis AG	Aminopyridinderivate als phosphatidylinositol-3-kinase-hemmer
CN106458979B (zh)	2014-04-24	2020-03-27	诺华股份有限公司	作为磷脂酰肌醇3-激酶抑制剂的氨基吡嗪衍生物
BR112016023967A2 (pt)	2014-04-24	2017-08-15	Novartis Ag	derivados de pirazina como inibidores de fosfatidilinositol 3-cinase
CN106659697B (zh) *	2014-05-30	2022-03-29	斯菲叶尔制药私有公司	作为抗结核剂的化合物
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
AU2015294889B2 (en)	2014-07-31	2018-03-15	Novartis Ag	Combination therapy
AU2020290094B2 (en)	2019-06-10	2024-01-18	Novartis Ag	Pyridine and pyrazine derivative for the treatment of CF, COPD, and bronchiectasis
PE20220346A1 (es)	2019-08-28	2022-03-14	Novartis Ag	Derivados de 1,3-fenil heteroarilo sustituidos y su uso en el tratamiento de enfermedades
CN110759904B (zh) *	2019-10-21	2023-03-14	河南科技大学	9r-酰氧基奎宁类衍生物及其制备方法、奎宁或其衍生物的应用、植物源杀虫剂
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2762796A (en) *		1956-09-11		Iminodibenzyl derivative
GB1219606A (en)	1968-07-15	1971-01-20	Rech S Et D Applic Scient Soge	Quinuclidinol derivatives and preparation thereof
GB1246606A (en)	1969-04-28	1971-09-15	Starogardzkie Zakl Farma	Dibenzo-azepine derivatives
IL72788A (en)	1984-08-28	1989-07-31	Israel State	Bis quaternary oxy-bis methylene(or trimethylene)bis-n-quinuclidines,pyridines and piperidines,their preparation and antidotes against organophosphorus and carbamate poisoning containing them
GB2225574B (en)	1987-12-24	1991-04-24	Wyeth John & Brother Ltd	Heterocyclic compounds
GB8825505D0 (en) *	1988-11-01	1988-12-07	Pfizer Ltd	Therapeutic agents
GB8923590D0 (en) *	1989-10-19	1989-12-06	Pfizer Ltd	Antimuscarinic bronchodilators
GB9201751D0 (en)	1992-01-28	1992-03-11	Smithkline Beecham Plc	Compounds
GB9202443D0 (en) *	1992-02-05	1992-03-18	Fujisawa Pharmaceutical Co	A novel substituted-acetamide compound and a process for the preparation thereof
AU7545894A (en) *	1993-09-02	1995-03-22	Yamanouchi Pharmaceutical Co., Ltd.	Carbamate derivative and medicine containing the same
EP0747355A4 (de)	1994-02-10	1997-04-09	Yamanouchi Pharma Co Ltd	Neue carbamate und diese enthaltende arzneimittel
NO2005012I1 (no) *	1994-12-28	2005-06-06	Debio Rech Pharma Sa	Triptorelin og farmasoytisk akseptable salter derav
EP0863141B1 (de)	1995-10-13	2001-09-12	Banyu Pharmaceutical Co., Ltd.	Substituierte heteroaromatische derivate
AUPN862996A0 (en)	1996-03-13	1996-04-04	Fujisawa Pharmaceutical Co., Ltd.	A novel substituted-acetamide compound
PE92198A1 (es) *	1996-08-01	1999-01-09	Banyu Pharma Co Ltd	Derivados de 1,4-piperidina disustituida que contienen fluor
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DK1300407T4 (da) *	2000-06-27	2011-09-05	S A L V A T Lab Sa	Carbamater afledt af arylalkylaminer
ATE305468T1 (de) *	2000-12-22	2005-10-15	Almirall Prodesfarma Ag	Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten
SI1353919T1 (sl)	2000-12-28	2006-12-31	Almirall Prodesfarma Ag	Novi derivati kinuklidina in medicinske zmesi, kijih vsebujejo.
PL211250B1 (pl) *	2001-12-20	2012-04-30	Chiesi Farma Spa	Pochodne karbaminianu 1-alkilo-1-azoniabicyklo [2.2.2] oktanu, jej zastosowania, kompozycja farmaceutyczna zawierająca ten związek oraz związek pośredni
ES2203327B1 (es) *	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
KR20050052500A (ko) *	2002-09-19	2005-06-02	쉐링 코포레이션	사이클린 의존성 키나제 억제제로서의 이미다조피리딘

2002
- 2002-07-02 ES ES200201539A patent/ES2204295B1/es not_active Expired - Fee Related
2003
- 2003-06-25 EP EP03762514A patent/EP1519933B1/de not_active Expired - Lifetime
- 2003-06-25 AT AT03762514T patent/ATE467631T1/de not_active IP Right Cessation
- 2003-06-25 WO PCT/EP2003/006708 patent/WO2004005285A1/en not_active Ceased
- 2003-06-25 JP JP2004518575A patent/JP2005533826A/ja active Pending
- 2003-06-25 RU RU2005102585/04A patent/RU2314306C2/ru not_active IP Right Cessation
- 2003-06-25 BR BR0312216-6A patent/BR0312216A/pt not_active IP Right Cessation
- 2003-06-25 AU AU2003242757A patent/AU2003242757B2/en not_active Ceased
- 2003-06-25 CN CNB03820648XA patent/CN100404533C/zh not_active Expired - Fee Related
- 2003-06-25 US US10/518,714 patent/US7488735B2/en not_active Expired - Fee Related
- 2003-06-25 NZ NZ537341A patent/NZ537341A/xx unknown
- 2003-06-25 CA CA002492535A patent/CA2492535A1/en not_active Abandoned
- 2003-06-25 UA UAA200500839A patent/UA80832C2/uk unknown
- 2003-06-25 DE DE60332534T patent/DE60332534D1/de not_active Expired - Fee Related
- 2003-06-25 MX MXPA04012271A patent/MXPA04012271A/es active IP Right Grant
- 2003-06-27 UY UY27870A patent/UY27870A1/es not_active Application Discontinuation
- 2003-06-30 PE PE2003000662A patent/PE20040644A1/es not_active Application Discontinuation
- 2003-06-30 AR ARP030102368A patent/AR040351A1/es unknown
- 2003-06-30 MY MYPI20032447A patent/MY130803A/en unknown
- 2003-07-02 TW TW092118081A patent/TW200402420A/zh unknown
2004
- 2004-12-22 IL IL165923A patent/IL165923A/en not_active IP Right Cessation
- 2004-12-23 ZA ZA200410404A patent/ZA200410404B/xx unknown
- 2004-12-29 EC EC2004005519A patent/ECSP045519A/es unknown
2005
- 2005-01-12 NO NO20050164A patent/NO20050164L/no not_active Application Discontinuation
2008
- 2008-01-08 US US11/970,698 patent/US7718670B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2003242757A1 (en)	2004-01-23
ATE467631T1 (de)	2010-05-15
EP1519933A1 (de)	2005-04-06
ECSP045519A (es)	2005-03-10
AR040351A1 (es)	2005-03-30
MXPA04012271A (es)	2005-04-08
BR0312216A (pt)	2005-04-12
JP2005533826A (ja)	2005-11-10
US7718670B2 (en)	2010-05-18
RU2005102585A (ru)	2005-10-10
TW200402420A (en)	2004-02-16
US7488735B2 (en)	2009-02-10
US20060167042A1 (en)	2006-07-27
WO2004005285A1 (en)	2004-01-15
AU2003242757B2 (en)	2009-01-08
MY130803A (en)	2007-07-31
NO20050164L (no)	2005-04-04
ZA200410404B (en)	2005-09-05
PE20040644A1 (es)	2004-09-18
US20080234316A1 (en)	2008-09-25
CA2492535A1 (en)	2004-01-15
CN100404533C (zh)	2008-07-23
IL165923A0 (en)	2006-01-15
IL165923A (en)	2010-06-30
ES2204295B1 (es)	2005-08-01
NZ537341A (en)	2006-04-28
RU2314306C2 (ru)	2008-01-10
ES2204295A1 (es)	2004-04-16
UA80832C2 (en)	2007-11-12
EP1519933B1 (de)	2010-05-12
CN1678610A (zh)	2005-10-05
UY27870A1 (es)	2003-10-31

Publication	Publication Date	Title
ATE457980T1 (de)	2010-03-15	Aryloxime
ATE534648T1 (de)	2011-12-15	C-6-modifizierte indazolylpyrrolotriazine
DE50306589D1 (de)	2007-04-05	Wischblatt
ATE427876T1 (de)	2009-04-15	Luftkissenboot
ATE318817T1 (de)	2006-03-15	Aza-arylpiperazine
DE50212349D1 (de)	2008-07-17	Hirurgie
DE50212360D1 (de)	2008-07-24	Anfahrhilfesteuerungsvorrichtung
DE50301200D1 (de)	2005-10-20	Wischblatt
ATE349458T1 (de)	2007-01-15	Etonogestrelester
DE50309536D1 (de)	2008-05-15	Fadenabsaugvorrichtung
DE50310481D1 (de)	2008-10-23	Röntgenstativ
ATA1572002A (de)	2003-06-15	Managementspleisskassette
DE50307971D1 (de)	2007-09-27	Gelenklager
DE50302660D1 (de)	2006-05-11	Stopfmachine
DE50301960D1 (de)	2006-01-26	Hydrolager
DE50301464D1 (de)	2005-12-01	Schraubensicherung
DE50309499D1 (de)	2008-05-08	Librierwerkzeugen
ATA4142004A (de)	2005-12-15	Trägerverbau
ATE469773T1 (de)	2010-06-15	Zugöse
DE50305973D1 (de)	2007-01-25	Auffangwanne
DE50303317D1 (de)	2006-06-14	Einschub-leistungsschalter
DE50307628D1 (de)	2007-08-16	Getraenkehalter
ATA19152002A (de)	2004-11-15	Hubkupplung
DE50308979D1 (de)	2008-02-21	Einspritzventil
DE50209283D1 (de)	2007-03-08	Tropfbewässerungsrohr

Legal Events

Date	Code	Title	Description
2011-04-21	8339	Ceased/non-payment of the annual fee